Total Payments
$13,954
2024 Payments
$2,710
Companies
52
Transactions
853
Medicare Patients
3,454
Medicare Billing
$245,508
Payment Breakdown by Category
Food & Beverage$13,923 (99.8%)
Education$31.05 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,923 | 847 | 99.8% |
| Education | $31.05 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,911 | 79 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,266 | 51 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,229 | 82 | $0 (2024) |
| Novo Nordisk Inc | $1,144 | 125 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,141 | 68 | $0 (2024) |
| PFIZER INC. | $927.22 | 71 | $0 (2024) |
| Allergan, Inc. | $804.68 | 43 | $0 (2020) |
| Astellas Pharma US Inc | $611.06 | 24 | $0 (2024) |
| Lilly USA, LLC | $592.78 | 45 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $437.23 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,710 | 147 | ABBVIE INC. ($461.75) |
| 2023 | $2,866 | 152 | ABBVIE INC. ($818.28) |
| 2022 | $2,228 | 117 | ABBVIE INC. ($488.26) |
| 2021 | $894.95 | 66 | Boehringer Ingelheim Pharmaceuticals, Inc. ($214.41) |
| 2020 | $629.49 | 39 | Allergan, Inc. ($265.17) |
| 2019 | $1,392 | 95 | Novo Nordisk Inc ($158.26) |
| 2018 | $1,206 | 83 | Allergan Inc. ($206.04) |
| 2017 | $2,027 | 154 | AstraZeneca Pharmaceuticals LP ($274.34) |
All Payment Transactions
853 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Biological | ||||||
| 12/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Bone Health | ||||||
| 11/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Obesity | ||||||
| 10/25/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.21 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Bone Health | ||||||
| 10/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 766 | 1,151 | $199,506 | $43,374 |
| 2022 | 6 | 811 | 1,216 | $211,978 | $49,793 |
| 2021 | 7 | 978 | 1,496 | $258,958 | $85,768 |
| 2020 | 10 | 899 | 1,295 | $228,867 | $66,573 |
Total Patients
3,454
Total Services
5,158
Medicare Billing
$245,508
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 229 | 477 | $76,958 | $21,489 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 116 | 229 | $27,251 | $10,013 | 36.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 205 | 205 | $66,420 | $8,481 | 12.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 17 | 19 | $4,522 | $1,367 | 30.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Facility | 2023 | 18 | 22 | $4,554 | $1,029 | 22.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 181 | 199 | $19,801 | $994.36 | 5.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 224 | 495 | $79,695 | $23,401 | 29.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 216 | 216 | $69,984 | $10,747 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 132 | 233 | $27,727 | $10,472 | 37.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Facility | 2022 | 27 | 34 | $7,038 | $1,653 | 23.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 18 | 22 | $5,236 | $1,439 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 23 | $3,094 | $1,069 | 34.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 174 | 193 | $19,204 | $1,013 | 5.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 278 | 653 | $105,294 | $33,382 | 31.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 202 | 202 | $65,448 | $29,270 | 44.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 141 | 236 | $28,084 | $7,991 | 28.5% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Facility | 2021 | 32 | 35 | $7,245 | $4,400 | 60.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 18 | 18 | $5,832 | $2,608 | 44.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 35 | $5,957 | $2,231 | 37.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 59 | $7,128 | $2,055 | 28.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 23 | 23 | $5,474 | $1,914 | 35.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 175 | 193 | $19,154 | $983.09 | 5.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2021 | 15 | 23 | $7,452 | $883.31 | 11.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 19 | 19 | $1,891 | $50.26 | 2.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2020 | 213 | 213 | $65,604 | $26,505 | 40.4% |
About Dr. John Pomichter, M.D
Dr. John Pomichter, M.D is a Internal Medicine healthcare provider based in Hudson, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588606800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Pomichter, M.D has received a total of $13,954 in payments from pharmaceutical and medical device companies, with $2,710 received in 2024. These payments were reported across 853 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($13,923).
As a Medicare-enrolled provider, Pomichter has provided services to 3,454 Medicare beneficiaries, totaling 5,158 services with total Medicare billing of $245,508. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Hudson, NY
- Active Since 06/12/2006
- Last Updated 07/16/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588606800
Products in Payments
- UBRELVY (Drug) $1,070
- QULIPTA (Drug) $825.84
- FARXIGA (Drug) $818.31
- JARDIANCE (Drug) $801.56
- TRELEGY ELLIPTA (Drug) $777.69
- Ozempic (Drug) $600.80
- ELIQUIS (Drug) $429.66
- Veozah (Drug) $427.76
- Kerendia (Drug) $358.90
- TRINTELLIX (Drug) $321.60
- XIFAXAN (Drug) $319.28
- CHANTIX (Drug) $297.53
- MOUNJARO (Drug) $265.73
- SPIRIVA RESPIMAT (Drug) $262.68
- EVENITY (Biological) $245.94
- BYSTOLIC (Drug) $230.97
- VRAYLAR (Drug) $201.21
- GEMTESA (Drug) $200.37
- XARELTO (Drug) $199.49
- ANORO (Drug) $186.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hudson
Anton Lishmanov, M.d., Phd, M.D., PHD
Internal Medicine — Payments: $30,564
Internal Medicine $30,564
Monica Reed, Md, MD
Internal Medicine — Payments: $19,292
Internal Medicine $19,292
Manjinder Kaur, Do, DO
Internal Medicine — Payments: $18,392
Internal Medicine $18,392
Dr. Douglas Kast, D.o, D.O
Internal Medicine — Payments: $17,501
Internal Medicine $17,501
Esteban Ruiz, Md, MD
Internal Medicine — Payments: $10,607
Internal Medicine $10,607
Ramya Pinnamaneni, M.d, M.D
Internal Medicine — Payments: $7,876
Internal Medicine $7,876